• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

仅供研究使用的 QuantiFERON SARS-CoV-2 检测的准确性以及 CD4 和 CD8 T 细胞-SARS-CoV-2 反应的特征:与自制的干扰素-γ 释放检测的比较。

Accuracy of QuantiFERON SARS-CoV-2 research use only assay and characterization of the CD4 and CD8 T cell-SARS-CoV-2 response: comparison with a homemade interferon-γ release assay.

机构信息

Translational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.

Translational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy; Unità Operativa Semplice (UOS) Professioni Sanitarie Tecniche, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.

出版信息

Int J Infect Dis. 2022 Sep;122:841-849. doi: 10.1016/j.ijid.2022.07.049. Epub 2022 Jul 22.

DOI:10.1016/j.ijid.2022.07.049
PMID:35878802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9307287/
Abstract

OBJECTIVES

In this study, we aimed to characterize the SARS-CoV-2-specific T cell response detected by the QuantiFERON SARS-CoV-2 research use only assay in terms of accuracy and T cell subsets involved compared with a homemade interferon (IFN)-γ release assay (IGRA).

METHODS

We evaluated T cell response by the standardized QuantiFERON SARS-CoV-2 tubes (antigen [Ag]1 and Ag2) and a homemade IGRA quantifying IFN-γ response to SARS-CoV-2 spike peptides (homemade-IGRA-SPIKE test). We evaluated the T cell subsets mediating the specific response using flow cytometry.

RESULTS

We prospectively enrolled 66 individuals: COVID-19 or post-COVID-19 subjects and NO-COVID-19-vaccinated subjects, including healthy donors and immunocompromised subjects. The standardized kit detected 62.1% (41/66) of T cell responders. Ag2 tube showed a higher IFN-γ quantitative and qualitative response. Ag1 tube response was mainly mediated by CD4 T cells; Ag2 tube response was mediated by CD4 and CD8 T cells. The homemade-IGRA-SPIKE test detected a higher number of responders (52/66, 78.8%) than the QuantiFERON SARS-CoV-2 assay (P = 0.056). The response was found in both T cell subsets, although a higher magnitude and response rate was observed in the CD4 T cell subset.

CONCLUSION

The QuantiFERON SARS-CoV-2 response is mediated by CD4 and CD8 T cells. A lower number of responders is found compared with the homemade-IGRA-SPIKE test, likely because of the different peptide composition.

摘要

目的

在这项研究中,我们旨在根据准确性和涉及的 T 细胞亚群,描述 QuantiFERON SARS-CoV-2 研究用试剂盒检测到的 SARS-CoV-2 特异性 T 细胞反应,与自制的干扰素(IFN)-γ释放试验(IGRA)进行比较。

方法

我们通过标准化的 QuantiFERON SARS-CoV-2 管(抗原[Ag]1 和 Ag2)和一种用于量化针对 SARS-CoV-2 刺突肽的 IFN-γ反应的自制 IGRA(自制-IGRA-SPIKE 测试)评估 T 细胞反应。我们使用流式细胞术评估介导特异性反应的 T 细胞亚群。

结果

我们前瞻性地招募了 66 名个体:COVID-19 或 COVID-19 后患者和未接种 COVID-19 的疫苗接种者,包括健康供体和免疫功能低下的患者。标准化试剂盒检测到 62.1%(41/66)的 T 细胞反应者。Ag2 管显示出更高的 IFN-γ 定量和定性反应。Ag1 管反应主要由 CD4 T 细胞介导;Ag2 管反应由 CD4 和 CD8 T 细胞介导。自制-IGRA-SPIKE 测试比 QuantiFERON SARS-CoV-2 试剂盒检测到更多的反应者(52/66,78.8%)(P=0.056)。反应存在于两个 T 细胞亚群中,尽管在 CD4 T 细胞亚群中观察到更高的幅度和反应率。

结论

QuantiFERON SARS-CoV-2 反应由 CD4 和 CD8 T 细胞介导。与自制-IGRA-SPIKE 测试相比,反应者的数量较少,这可能是由于不同的肽组成。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2968/9307287/c17b7db8e8e5/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2968/9307287/39baf406fa9e/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2968/9307287/e0eb36bbf972/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2968/9307287/c17b7db8e8e5/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2968/9307287/39baf406fa9e/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2968/9307287/e0eb36bbf972/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2968/9307287/c17b7db8e8e5/gr3_lrg.jpg

相似文献

1
Accuracy of QuantiFERON SARS-CoV-2 research use only assay and characterization of the CD4 and CD8 T cell-SARS-CoV-2 response: comparison with a homemade interferon-γ release assay.仅供研究使用的 QuantiFERON SARS-CoV-2 检测的准确性以及 CD4 和 CD8 T 细胞-SARS-CoV-2 反应的特征:与自制的干扰素-γ 释放检测的比较。
Int J Infect Dis. 2022 Sep;122:841-849. doi: 10.1016/j.ijid.2022.07.049. Epub 2022 Jul 22.
2
Performance comparison of a flow cytometry immunoassay for intracellular cytokine staining and the QuantiFERON® SARS-CoV-2 test for detection and quantification of SARS-CoV-2-Spike-reactive-IFN-γ-producing T cells after COVID-19 vaccination.流式细胞术免疫分析与 QuantiFERON® SARS-CoV-2 试验在检测和定量 COVID-19 疫苗接种后 SARS-CoV-2 刺突反应性 IFN-γ 产生 T 细胞方面的性能比较。
Eur J Clin Microbiol Infect Dis. 2022 Apr;41(4):657-662. doi: 10.1007/s10096-022-04422-7. Epub 2022 Feb 15.
3
Performance of the Roche Elecsys® IGRA SARS-CoV-2 test for the detection and quantification of virus-reactive T cells in COVID-19-vaccinated immunosuppressed patients and healthy subjects.罗氏 Elecsys® IGRA SARS-CoV-2 检测试剂盒用于检测和定量 COVID-19 疫苗接种免疫抑制患者和健康受试者体内病毒反应性 T 细胞的性能。
Eur J Clin Microbiol Infect Dis. 2024 Jul;43(7):1427-1436. doi: 10.1007/s10096-024-04852-5. Epub 2024 May 23.
4
Clinical Performance of a Standardized Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Interferon-γ Release Assay for Simple Detection of T-Cell Responses After Infection or Vaccination.一种标准化严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)干扰素-γ释放检测试剂盒的临床性能,用于简单检测感染或接种疫苗后的 T 细胞反应。
Clin Infect Dis. 2022 Aug 24;75(1):e338-e346. doi: 10.1093/cid/ciab1021.
5
IFN-γ cell response and IFN-γ release concordance after in vitro SARS-CoV-2 stimulation.体外 SARS-CoV-2 刺激后 IFN-γ 细胞反应和 IFN-γ 释放的一致性。
Eur J Clin Invest. 2021 Dec;51(12):e13636. doi: 10.1111/eci.13636. Epub 2021 Jun 24.
6
CD69 flow cytometry to complement interferon-γ release assay for active tuberculosis.采用CD69流式细胞术辅助干扰素-γ释放试验诊断活动性肺结核。
Cytometry B Clin Cytom. 2022 Nov;102(6):471-486. doi: 10.1002/cyto.b.22093. Epub 2022 Sep 26.
7
Pre-existing T-cell immunity to SARS-CoV-2 in unexposed healthy controls in Ecuador, as detected with a COVID-19 Interferon-Gamma Release Assay.在厄瓜多尔未接触过 SARS-CoV-2 的健康对照者中,使用 COVID-19 干扰素释放分析检测到预先存在的针对 SARS-CoV-2 的 T 细胞免疫。
Int J Infect Dis. 2021 Apr;105:21-25. doi: 10.1016/j.ijid.2021.02.034. Epub 2021 Feb 12.
8
Comparative Results of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus Assays for Detection of Tuberculosis Infection in Clinical Samples.全血γ-干扰素释放试验和增强版全血γ-干扰素释放试验检测临床样本中结核感染的比较结果
J Clin Microbiol. 2020 Mar 25;58(4). doi: 10.1128/JCM.01854-19.
9
Characterization of specific CD4 and CD8 T-cell responses in QuantiFERON TB Gold-Plus TB1 and TB2 tubes.在QuantiFERON TB Gold-Plus TB1和TB2管中特定CD4和CD8 T细胞反应的特征分析
Tuberculosis (Edinb). 2018 Dec;113:239-241. doi: 10.1016/j.tube.2018.10.014. Epub 2018 Nov 1.
10
Evaluation of interferon gamma release assay to measure t-cell response in COVID-19 patients from intensive care units and inpatient departments.评估干扰素γ释放试验以测定重症监护病房和住院部COVID-19患者的T细胞反应。
Bratisl Lek Listy. 2024;125(9):533-538. doi: 10.4149/BLL_2024_83.

引用本文的文献

1
Anti-SARS-CoV-2 B and T-Cell Immune Responses Persist 12 Months After mRNA Vaccination with BNT162b2 in Systemic Lupus Erythematosus Patients Independently of Immunosuppressive Therapies.在系统性红斑狼疮患者中,使用BNT162b2进行mRNA疫苗接种后,抗SARS-CoV-2 B细胞和T细胞免疫反应持续12个月,与免疫抑制治疗无关。
Vaccines (Basel). 2025 Apr 9;13(4):396. doi: 10.3390/vaccines13040396.
2
Prolonged SARS-CoV-2 Infection in Patients Receiving Anti-CD20 Monoclonal Antibodies: A Diagnostic Challenged by Negative Nasopharyngeal RT-PCR and Successful Treatment with COVID-19 High-Titer Convalescent Plasma.接受抗 CD20 单克隆抗体治疗的患者中 SARS-CoV-2 感染的长期持续:鼻咽 RT-PCR 检测结果为阴性带来的诊断挑战,以及 COVID-19 高滴度恢复期血浆治疗的成功。
Viruses. 2023 Nov 7;15(11):2220. doi: 10.3390/v15112220.
3

本文引用的文献

1
Humoral and Cellular Response to Spike of Delta SARS-CoV-2 Variant in Vaccinated Patients With Multiple Sclerosis.多发性硬化症疫苗接种患者对新冠病毒Delta变异株刺突蛋白的体液和细胞反应
Front Neurol. 2022 May 31;13:881988. doi: 10.3389/fneur.2022.881988. eCollection 2022.
2
T-cell proliferation assay for the detection of SARS-CoV-2-specific T-cells.用于检测 SARS-CoV-2 特异性 T 细胞的 T 细胞增殖检测。
Clin Chim Acta. 2022 Jul 1;532:130-136. doi: 10.1016/j.cca.2022.05.025. Epub 2022 Jun 8.
3
Humoral and cellular responses to spike of δ SARS-CoV-2 variant in vaccinated patients with immune-mediated inflammatory diseases.
A two-arm analysis of the immune response to heterologous boosting of inactivated SARS-CoV-2 vaccines.两臂分析对灭活 SARS-CoV-2 疫苗异源加强的免疫反应。
Sci Rep. 2023 Oct 31;13(1):18762. doi: 10.1038/s41598-023-46053-8.
4
Impact of different classes of immune-modulating treatments on B cell-related and T cell-related immune response before and after COVID-19 booster vaccination in patients with immune-mediated diseases and primary immunodeficiency: a cohort study.免疫调节治疗对免疫介导性疾病和原发性免疫缺陷患者 COVID-19 加强疫苗接种前后 B 细胞相关和 T 细胞相关免疫反应的影响:一项队列研究。
RMD Open. 2023 Aug;9(3). doi: 10.1136/rmdopen-2023-003094.
5
BNT162b2 Elicited an Efficient Cell-Mediated Response against SARS-CoV-2 in Kidney Transplant Recipients and Common Variable Immunodeficiency Patients.BNT162b2 在肾移植受者和普通可变免疫缺陷患者中引发了针对 SARS-CoV-2 的有效细胞介导反应。
Viruses. 2023 Jul 30;15(8):1659. doi: 10.3390/v15081659.
6
The Importance of Measuring SARS-CoV-2-Specific T-Cell Responses in an Ongoing Pandemic.在持续的大流行中测量新冠病毒特异性T细胞反应的重要性。
Pathogens. 2023 Jun 22;12(7):862. doi: 10.3390/pathogens12070862.
7
Integration of Cellular and Humoral Immune Responses as an Immunomonitoring Tool for SARS-CoV-2 Vaccination in Healthy and Fragile Subjects.细胞和体液免疫反应的整合作为健康和脆弱人群中 SARS-CoV-2 疫苗接种的免疫监测工具。
Viruses. 2023 May 30;15(6):1276. doi: 10.3390/v15061276.
8
Improved Performance of the QuantiFERON-SARS-CoV-2 Assay with the Extended Set.扩展集可提高 QuantiFERON-SARS-CoV-2 检测的性能。
Viruses. 2023 May 17;15(5):1179. doi: 10.3390/v15051179.
9
Cytokine Response Following SARS-CoV-2 Antigen Stimulation in Patients with Predominantly Antibody Deficiencies.在以抗体缺陷为主的患者中,SARS-CoV-2 抗原刺激后的细胞因子反应。
Viruses. 2023 May 10;15(5):1146. doi: 10.3390/v15051146.
10
Dynamic Evolution of Humoral and T-Cell Specific Immune Response to COVID-19 mRNA Vaccine in Patients with Multiple Sclerosis Followed until the Booster Dose.COVID-19 mRNA 疫苗接种后多发性硬化症患者体液和 T 细胞特异性免疫应答的动态演变直至加强针。
Int J Mol Sci. 2023 May 10;24(10):8525. doi: 10.3390/ijms24108525.
体液和细胞应答对免疫介导的炎症性疾病患者中δ SARS-CoV-2 变异株刺突的反应。
Int J Infect Dis. 2022 Aug;121:24-30. doi: 10.1016/j.ijid.2022.04.027. Epub 2022 Apr 22.
4
Persistent Spike-specific T cell immunity despite antibody reduction after 3 months from SARS-CoV-2 BNT162b2-mRNA vaccine.在接种 SARS-CoV-2 BNT162b2-mRNA 疫苗 3 个月后,尽管抗体减少,但 Spike 特异性 T 细胞免疫仍持续存在。
Sci Rep. 2022 Apr 23;12(1):6687. doi: 10.1038/s41598-022-07741-z.
5
Kinetics of the B- and T-Cell Immune Responses After 6 Months From SARS-CoV-2 mRNA Vaccination in Patients With Rheumatoid Arthritis.类风湿关节炎患者接种SARS-CoV-2 mRNA疫苗6个月后B细胞和T细胞免疫反应的动力学
Front Immunol. 2022 Feb 28;13:846753. doi: 10.3389/fimmu.2022.846753. eCollection 2022.
6
Development of a T cell-based immunodiagnostic system to effectively distinguish SARS-CoV-2 infection and COVID-19 vaccination status.开发一种基于 T 细胞的免疫诊断系统,以有效区分 SARS-CoV-2 感染和 COVID-19 疫苗接种状态。
Cell Host Microbe. 2022 Mar 9;30(3):388-399.e3. doi: 10.1016/j.chom.2022.02.003. Epub 2022 Feb 8.
7
Performance comparison of a flow cytometry immunoassay for intracellular cytokine staining and the QuantiFERON® SARS-CoV-2 test for detection and quantification of SARS-CoV-2-Spike-reactive-IFN-γ-producing T cells after COVID-19 vaccination.流式细胞术免疫分析与 QuantiFERON® SARS-CoV-2 试验在检测和定量 COVID-19 疫苗接种后 SARS-CoV-2 刺突反应性 IFN-γ 产生 T 细胞方面的性能比较。
Eur J Clin Microbiol Infect Dis. 2022 Apr;41(4):657-662. doi: 10.1007/s10096-022-04422-7. Epub 2022 Feb 15.
8
SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron.SARS-CoV-2 疫苗接种可诱导能够交叉识别 Alpha 到奥密克戎变体的免疫 T 细胞记忆。
Cell. 2022 Mar 3;185(5):847-859.e11. doi: 10.1016/j.cell.2022.01.015. Epub 2022 Jan 24.
9
Long-Term Accuracy of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Interferon-γ Release Assay and Its Application in Household Investigation.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)干扰素-γ释放试验的长期准确性及其在家庭调查中的应用
Clin Infect Dis. 2022 Aug 24;75(1):e314-e321. doi: 10.1093/cid/ciac045.
10
Immune-Guided Therapy of COVID-19.COVID-19 的免疫导向治疗。
Cancer Immunol Res. 2022 Apr 1;10(4):384-402. doi: 10.1158/2326-6066.CIR-21-0675.